Skip to main content
KimeraCHEMS
Display
Out of stock
  • C
  • N
  • O

Calculated reference model · not an experimental or batch-certified structure. All 34 atoms shown.

Model data & sources
  • Heavy atoms only; hydrogens are omitted from the reference display.
  • Source-defined stereochemistry is checked against the calculated coordinates; no energy-minimum, crystal or solution-structure claim is made.
  • Reference molecular species only; batch identity, purity, counterions and excipients are not certified.
Formula
C25H34N6O3
Method
RDKit ETKDGv3 / MMFF94s calculated reference conformer

Acetildenafil

Phosphodiesterase Inhibitors

Published formats

  • Dry-Fill Capsule 60ct/30mg/1.8g
  • Powder 2g
What is the difference between these?
Dry-Fill Capsule
Capsules filled with the weighed solid. The label gives the amount in each capsule and the number in the bottle.
Powder
Raw material as a solid. Nothing added and nothing portioned; the stated weight is what is in the container.
Each label gives the amount per unit and the total, so compare the totals rather than the container size.

Supplementary product details from the published catalog, checked 2026-10-07. These reference details do not establish current availability.

Pricing

Pricing and order placement are reserved for reviewed research accounts. Log in or submit an account application to view current product pricing.

Want to be notified when this product is back in stock?

Technical Specifications

Batch COA Database ↗
CAS Registry Number831217-01-7
Molecular FormulaC25H34N6O3
Molecular Weight466.58
IUPAC Designation5-[2-ethoxy-5-[2-(4-ethyl-1-piperazinyl)acetyl]phenyl]-1,6-dihydro-1-methyl-3-propyl-7H-pyrazolo[4,3-d]pyrimidin-7-one
Physical FormWhite to off-white powder
Storage RequirementsRefer to product documentation
Other NamesHongdenafil, 7H-Pyrazolo[4,3-d]pyrimidin-7-one, 5-[2-ethoxy-5-[2-(4-ethyl-1-piperazinyl)acetyl]phenyl]-1,6-dihydro-1-methyl-3-propyl-
Capsule Concentration30mg x 60ct
Bulk Powder Quantity2g

Identity fields from the published product record, checked 2026-10-07. Reference information is not a batch identity certificate.

Research Overview

Acetildenafil Research Standard

Acetildenafil is a synthetic chemical compound and a structural analogue of sildenafil. Classified within the chemical family of phosphodiesterase type 5 (PDE5) inhibitors, it functions primarily as an investigative reference standard in analytical toxicology and pharmacology. In research environments, acetildenafil is utilized to characterize the structure-activity relationship (SAR) of PDE5-inhibitory scaffolds and as a benchmark analyte for the detection and identification of undeclared substances in complex matrices.

Image Alt Text: Chemical structure representation of Acetildenafil, a PDE5 inhibitor analogue.

Physical & Handling Properties

Property Specification
Physical Appearance White to off-white powder

Mechanism of Action & Research Context

Acetildenafil is investigated for its capacity to inhibit the phosphodiesterase type 5 (PDE5) enzyme, which is responsible for the degradation of cyclic guanosine monophosphate (cGMP) in specific tissues.

  • Enzyme Inhibition: Like other sildenafil-related analogues, acetildenafil is studied for its ability to bind the catalytic site of PDE5. This inhibits the hydrolysis of cGMP, thereby maintaining elevated intracellular levels of this secondary messenger in experimental models.

  • Structural Comparison: Research focuses on how the structural modifications in the acetildenafil scaffold—compared to the parent sildenafil molecule—affect binding affinity, potency, and selectivity profiles against PDE5 and other phosphodiesterase isoenzymes.

  • Analytical Marker: Due to its occasional presence as an undeclared component in regulated samples, acetildenafil serves as a critical reference standard for validating LC-MS/MS and GC-MS screening methods used in forensic and regulatory laboratories.

Research Applications

Acetildenafil is a specialized reagent essential for analytical chemistry and pharmacological research.

Primary fields of laboratory investigation include:

  • Analytical Method Development: Validation of high-sensitivity screening panels to detect PDE5 analogues in complex biological or chemical samples.

  • Structure-Activity Relationship (SAR): Mapping how the acetildenafil molecular structure influences the modulation of PDE signaling pathways.

  • Pharmacological Benchmarking: Comparing the potency and kinetic binding profiles of acetildenafil against standardized PDE5 inhibitors like sildenafil or vardenafil.

  • Toxicological Profiling: Assisting in the forensic identification of novel designer-drug analytes in research settings.

Storage & Handling Guidelines

Store at controlled room temperature. Keep tightly closed.

Storage guidance is a house recommendation. Analytical documentation is per-lot release testing.

Related Research Compounds

Research Use Disclaimer

Research Use Only Disclaimer: This product is labeled and sold "For Research Use Only - NOT FOR HUMAN CONSUMPTION." It is not a drug, dietary supplement, food, cosmetic, or medical device, and it is not approved by the FDA or any other regulator for human or veterinary use. It is supplied to approved account holders as a research chemical for laboratory use and must be handled in accordance with applicable law.

Certificates of Analysis

Kimera Chems

Compounds That Survive Scrutiny

Research use only. Not for human or veterinary use.